{"schema_version":"secwatch.filing_event.v1","accession":"0001420800-26-000008","form_type":"8-K","ticker":"ENOV","cik":"0001420800","company_name":"Enovis CORP","filed_at":"2026-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.044234+00:00","generated_at":"2026-05-15T23:30:25.319938+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Enovis posts FY2025 net loss of $1.18B including $1.05B goodwill impairment; Q4 sales $576M","bullets":["Full-year 2025 net sales $2.2B, up 7% reported/6% organic; Recon sales +10%, P&R +4%.","Q4 net loss $519M includes $501M non-cash goodwill impairment; adjusted EPS $0.95.","Full-year adjusted EBITDA $403M; adjusted diluted EPS $3.30.","2026 guidance: revenue $2.31-2.37B (4-6% organic growth), adjusted EBITDA $425-435M, adjusted EPS $3.52-3.73.","CEO cites operational progress, Lima integration, and debt reduction; outlook reflects cautious macro view."],"urls":{"canonical":"https://secwatch.observer/filing/0001420800-26-000008","json":"https://secwatch.observer/filing/0001420800-26-000008.json","markdown":"https://secwatch.observer/filing/0001420800-26-000008.md","text":"https://secwatch.observer/filing/0001420800-26-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420800/000142080026000008/0001420800-26-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420800/000142080026000008/cfx-20260226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:30:25.319938+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}